GAGA Share Market News

[hfe_template id='11223'] [ad_1] Shares of Indian pharmaceutical companies, including Aurobindo Pharma, Laurus Labs, IPCA Laboratories, and Lupin, dropped as much as 7% on Friday after U.S. President Donald Trump signaled that tariffs on the sector were imminent. Speaking to reporters aboard Air Force One, Trump stated that his administration was evaluating potential tariffs on pharmaceuticals. “Pharma is going to start coming in at, I think, a level that you haven’t really seen before,” he said, hinting at forthcoming trade measures. He further clarified that pharmaceuticals were being considered as a separate category for tariffs, with an announcement expected soon. “We are looking at pharma as a separate category. We will be announcing that sometime in the near future—not in the distant future,” he added. The remarks come just a day after pharma stocks had rallied on expectations that the sector would be spared from trade restrictions. On Thursday, the Nifty Pharma in...

[hfe_template id='11223'] [ad_1] Indian pharmaceutical stocks fell up to 3% on the BSE on Thursday amid fears of tariffs by US President Donald Trump, with a fresh setback from the announcements in the auto sector having a rub-off impact. Shares of Aurobindo Pharmaceuticals fell 2% to their day’s low of Rs 1,132.75 while those of Ipca Laboratories went down by 2.7% to Rs 1,403.95. Sun Pharmaceuticals and Dr Reddy’s Laboratories shares tumbled 1.7% each and Ajanta Pharma shares slid by 2.5%. Meanwhile, the shares of Zydus Lifesciences, Alkem Laboratories, Lupin, and Natco Pharma were trading lower between 1% and 1.5% around 10:20 am. Speaking to reporters at the White House, Trump, in a previous speech, said the United States would need all those products if there were problems including wars. "We've been ripped off by every country," Trump said as he presided over a meeting of his Cabinet. Live Events Commerce Secretary Howard Lutnick, during the same meeti...

[hfe_template id='11223'] [ad_1] Domestic markets traded in a narrow range on Friday and ended almost flat, pausing after two consecutive sessions of gains. In today's session, shares of Gensol Engineering, HCL Tech, Tata Power, NMDC, IndusInd Bank among others will be in focus due to various news developments. HCL Tech Shiv Nadar inked a gift deed to give 47% shareholding of HCL Corp and Vama Delhi each to his daughter Roshni Nadar Malhotra. RailTel RailTel bagged a work order worth Rs 28.29 crore from Northern Railway. Tata Power Tata Power's arm Tata Power Renewable Energy has signed a memorandum of understanding (MoU) with the government of Andhra Pradesh to collaborate on renewable energy projects in the state. JSW Steel Crude Steel Production was up around 12% YoY At 24.07 lakh tonnes versus 21.50 lakh tonnes. Shilpa Medicare US FDA issued a Form 483 with 1 observation for Raichur-based Unit-1 of its arm Shilpa Pharma Lifesciences. ONGC ONGC arm ONGC Petro ...

[hfe_template id='11223'] [ad_1] Shares of Lupin Ltd fell as much as 2.8% on Wednesday to Rs 2,008 on the BSE amid a broader market weakness despite posting a year-on-year profit increase for the third quarter ended December 2024. Lupin reported a profit after tax of Rs 8,589 crore for the December quarter, marking a 38.8% increase from Rs 6,187 crore a year earlier. Total revenue from operations surged 102.7% in the third quarter to Rs 57,677 crore, reflecting strong demand across key markets. The company’s earnings before interest, tax, depreciation, and amortization (EBITDA) rose 25.1% in the December quarter to Rs 14,096 crore, with EBITDA margins inching up to 21.1% from 21% a year ago. The stock, which closed 4.68% lower in the previous session at Rs 2,067.95, has gained 29.7% over the past year but remains under pressure in recent weeks. It has fallen 3.6% over the last five trading sessions and is down 3.7% over the past six months. The company’s balance sheet di...

[hfe_template id='11223'] [ad_1] The Indian market is likely to trade higher on Friday, tracking positive global cues. The Nifty futures closed in the negative with losses of 0.09%, at the 23,748 levels on Thursday. On the options front, the maximum Call OI is placed at 24,000, followed by the 25,000 strikes, while the maximum Put OI is placed at 23,800, followed by the 23,000 strikes. Call writing is seen at 23,800 and then at the 24,000 strikes, while Put writing is seen at 23,800 and then at the 23,000 strikes. “Options data suggests a broader trading range between the 23,200 to 24,200 zones, with an immediate range between the 23,500 to 23,900 levels,” said Chandan Taparia, Head of Equity Derivatives & Technicals at Wealth Management, MOFSL. “Nifty formed a Doji-like candle on the daily chart on Thursday, showing multiple Dojis, which indicates indecisiveness. A lack of follow-up buying is preventing the index from making any significant movement,” he said.“Now, ...

[hfe_template id='11223'] [ad_1] Shares of Lupin will remain in focus on Thursday after the drugmaker received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for HIV tablets emtricitabine and tenofovir alafenamide tablets, 200 mg/25 mg. "We wish to confirm that the Company has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Emtricitabine and Tenofovir Alafenamide Tablets, 200 mg/25 mg, to market a generic equivalent of Descovy® Tablets, 200 mg/25 mg of Gilead Sciences, Inc," Lupin said in an exchange filing. The approval allows Lupin to market a generic version of Descovy tablets, a product originally developed by Gilead Sciences Inc. Lupin is one of the first companies to receive approval for this generic formulation, making it eligible for 180 days of shared generic exclusivity in the US market. The product will be manu...

[hfe_template id='11223'] [ad_1] The Indian equity market concluded Friday with a 0.5% weekly gain, led by gains in banking, financial, and metal stocks. As markets reopen on Monday, a mix of domestic and international events—including Q2 earnings reports, the US election, and global market dynamics—will likely shape market movements. On Friday, the Nifty 50 and BSE Sensex rose by 0.41% and 0.42%, respectively, during a special Diwali "muhurat" trading session. Auto stocks led this upward move, bolstered by strong monthly sales data. "The domestic market showed positive reversal signs this week, aided by festive sentiment, steady institutional inflows, and declining oil prices," said Vinod Nair, Head of Research at Geojit Financial Services. Market sentiment was also uplifted by easing geopolitical tensions and positive India-China relations. Q2 Earnings Investors will closely watch corporate earnings as the next batch of Q2FY25 results to be released...

[hfe_template id='11223'] [ad_1] Indian Railway Finance Corporation Share Price 152.07 04:08 PM | 4 Oct 2024 0.47(0.32%) Suzlon Energy Share Price 74.67 04:08 PM | 4 Oct 2024 -1.08(-1.43%) Indian Renewable Energy Development Agency Share Price 221.66 04:08 PM | 4 Oct 2024 -1.66(-0.75%) Tata Motors Share Price 930.75 04:08 PM | 4 Oct 2024 5.05(0.55%) YES Bank Share Price 21.95 04:08 PM | 4 Oct 2024 0.09(0.42%) HDFC Bank Share Price 1657.65 04:08 PM | 4 Oct 2024 -24.35(-1.45%) NHPC Share Price 93.17 04:08 PM | 4 Oct 2024 0.22(0.23%) Rail Vikas Nigam Share Price 493.4 04:08 PM | 4 Oct 2024 -16.11(-3.16%) State Bank of India Share Price 796.65 04:08 PM | 4 Oct 2024 2.55(0.33%) Tata Power Company Share Price 466.65 04:08 PM | 4 Oct 2024 -5.16(-1.1%) Tata Steel Share Price 166.75 04:08 PM | 4 Oct 2024 -0.23(-0.14%) Adani Power Share Price 642.1 04:08 PM | 4 Oct 2024 -2.65(-0.42%) One97 Communications Share Price 695.15 04:08 PM | 4 Oct 2024 -32.4(-4.46%) Punjab National Bank S...

[hfe_template id='11223'] [ad_1] Indian Railway Finance Corporation Share Price 178.62 03:59 PM | 30 Aug 2024 -1.32(-0.74%) One97 Communications Share Price 621.9 03:59 PM | 30 Aug 2024 67.4(12.16%) YES Bank Share Price 23.61 03:59 PM | 30 Aug 2024 -0.13(-0.51%) ITC Share Price 501.9 03:59 PM | 30 Aug 2024 -3.21(-0.64%) HDFC Bank Share Price 1636.9 03:59 PM | 30 Aug 2024 -1.65(-0.11%) Tata Motors Share Price 1111.35 03:59 PM | 30 Aug 2024 -10.31(-0.92%) Zomato Share Price 250.53 03:59 PM | 30 Aug 2024 -1.82(-0.72%) Adani Enterprises Share Price 3019.35 03:57 PM | 30 Aug 2024 -0.81(-0.03%) Infosys Share Price 1943.7 03:59 PM | 30 Aug 2024 10.36(0.54%) Reliance Industries Share Price 3019.25 03:59 PM | 30 Aug 2024 -22.6(-0.75%) Adani Power Share Price 632.05 03:59 PM | 30 Aug 2024 -12.25(-1.91%) Vedanta Share Price 468.45 03:59 PM | 30 Aug 2024 5.06(1.09%) Indian Renewable Energy Development Agency Share Price 241.5 03:59 PM | 30 Aug 2024 -13.25(-5.21%) NHPC Share Price 96...

[hfe_template id='11223'] [ad_1] Domestic markets sustained their upward trajectory into the new week as indices reached fresh highs on Monday. In today's trade, shares of Bajaj Auto, SpiceJet, Jio Financial, HUL, Vedanta, ZEE among others will be in focus due to various news developments and first quarter results. Bajaj Auto, L&T Finance, Just Dial Shares of Bajaj Auto, L&T Finance and Just Dial will be in focus as the companies will announce their first quarter results today. Vedanta Mining giant Vedanta Ltd has announced the launch of its qualified institutional placement (QIP) issue on Monday and fixed a floor price at Rs 461.2 apiece. SpiceJet Budget carrier SpiceJet reported consolidated net profit of Rs 127 crore in the fourth quarter ended March 2024 as against a loss a year ago. Jio Financial Jio Financial Services on Monday reported a 6% year-on-year decline in its June quarter net profit at Rs 313 crore. ZEE Zee Entertainment Enterprises (Zee) has ...

[hfe_template id='11223'] [ad_1] DHARMESH SHAH, HEAD OF TECHNICALS, ICICI SECURITIES Where is Nifty headed this week? We expect Nifty to continue trade with a positive bias and gradually head towards 24,700 by July end. Higher peaks and troughs supported by market breadth signifies inherent strength (currently 86% of stocks are trading above 50-day EMAs), and the global setup continues to remain on strong footing and, barring minor retracements, does not flag higher volatility. What should investors do? Past five week’s sharp up-move of 15% has hauled the weekly stochastic oscillator in overbought territory (at 95). Thus, the possibility of a temporary breather at higher levels cannot be ruled out ahead of the budget and the June quarter earnings season. Hence, any dip should not be construed as negative. Instead, it will be a buying opportunity as key support is at 23,700. Sectorally, BFSI, IT, oil & gas, capital goods, infra, pharma, and PSU are expected to do well...

[hfe_template id='11223'] [ad_1] Shares of Lupin fell 5% to Rs 1,598.3 in Tuesday's trade on BSE despite the pharma firm reported a 52% year-on-year (YoY) growth in its consolidated net profit at Rs 368 crore for the quarter ended March 2024. The same stood at Rs 242 crore in the last year quarter. Its revenue from operations in the same period jumped 12% YoY to Rs 4,961 crore as against Rs 4430 crore in the corresponding period of last year. EBITDA for the reporting quarter rose by a robust 67% YoY to Rs 1,026 crore. It was Rs 615 crore a year ago. EBITDA margins, meanwhile, expanded 680 basis points compared with the year-ago period to 21%. Following the Q4 results, global brokerage firm JPMorgan maintained a 'Neutral' rating on Lupin with a target price of Rs 1550. "The Q4 was broadly in line with estimates and margins were ahead of expectations. The key positives are margin improvement, continued strength in EMEA, and reduction in net debt," JPM...